Drug profile

The FDA adverse-event record for Telazol

16 FDA reports name Telazol, a lower-volume drug in the CVM extract. Species, reactions, and outcomes follow.

#2059 of 2,679
by report volume (all drugs)
16
adverse-event reports
43.8%
death-coded share
Cat
most-reported species
Verify with FDA CVM →

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Telazol ranks #1995 of 2679 by total reports (16). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#1995
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Telazol has 16 reports now versus 16 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Telazol changes

Signature read: Telazol's 43.8% death-coded share is among the highest in the openFDA drug corpus.

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
16
Total Reports
7
Deaths Reported
43.8%
Death-coded share of reports

Active Ingredients

Telazol

Administration Routes

UnknownIntramuscularIntravenous

Species Affected

Cat 10
Dog 6

Most Affected Breeds

Domestic Shorthair 5
Shepherd Dog - German 2
Persian 2
Schnauzer - Miniature 1
Russian 1
Dog (unknown) 1
Boxer (German Boxer) 1
Domestic Mediumhair 1
Sphynx 1
Shepherd Dog - Australian 1

Most Reported Reactions

Death 7
Medication error NOS 4
Cyanosis 3
Vocalisation 2
Diarrhoea 2
Increased respiratory rate 2
Nasal discharge 2
Elevated temperature 2
Open mouth breathing 2
Abnormal radiograph finding 2
Injection site alopecia 1
Vasculitis 1

Outcome Breakdown

Died
6 (37.5%)
Recovered/Normal
4 (25.0%)
Outcome Unknown
2 (12.5%)
Ongoing
2 (12.5%)
Recovered with Sequela
1 (6.3%)
Euthanized
1 (6.3%)

Telazol: high death-coded share in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

What to do with this drug

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Telazol (#2059 of 2,679 by report volume); death-coded 43.8%. PlainBreed drug row · death-coded share stamp 43.8% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →